Latest Apolipoprotein E Stories
THESSALONIKI, Macedonia, Greece, March 9 /PRNewswire/ -- Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, announced data which showed that augmentation with ketone bodies significantly improved cognitive function in Alzheimer's disease (AD) patients.
Researchers at Universitat AutÃ²noma de Barcelona (UAB) and University of Stockholm have created a computer modeling of the structural malfunctioning of the ApoE4 protein when it enters into contact with the Amyloid beta molecule, the main cause of Alzheimer's disease.
Genetic adaption to meat-rich diets may also lead to high rates of Alzheimer's and heart disease.
The low-density lipoprotein receptor (LDLR) has received a lot of attention because of its connection with coronary heart disease and atherosclerosis, but now it appears as if it may have a beneficial influence in degenerative brain diseases.
Reversing abnormal brain activity in Alzheimer models improves development of new nerve cells born in adult brains.
Human genes have adapted to inflammation, but we are more susceptible to diseases of aging.
Brain imaging can offer a window into risk for diseases such as Alzheimer's disease (AD).
NORTH CHICAGO, Ill., Nov. 13 /PRNewswire-USNewswire/ -- Research that is targeting the early diagnosis of Alzheimer disease has drawn national attention to the work of Michael Seidenberg, PhD, a faculty member at Rosalind Franklin University of Medicine and Science. Dr.
ST. LOUIS, Oct.
The action of a small protein that is a major villain in Alzheimer's disease can be counterbalanced with another brain protein, researchers at UT Southwestern Medical Center have found in an animal study.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.